Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection

Br J Haematol. 2020 Sep;190(5):e274-e276. doi: 10.1111/bjh.17014. Epub 2020 Aug 23.
No abstract available

Keywords: COVID-19; SARS-CoV-2; acute lymphoblastic leukaemia (ALL); chemotherapy; remdesivir.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenosine Monophosphate / administration & dosage
  • Adenosine Monophosphate / analogs & derivatives*
  • Alanine / administration & dosage
  • Alanine / analogs & derivatives*
  • Betacoronavirus / metabolism*
  • COVID-19
  • Child, Preschool
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / drug therapy
  • Coronavirus Infections* / etiology
  • Humans
  • Induction Chemotherapy*
  • Male
  • Pandemics*
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / drug therapy
  • Pneumonia, Viral* / etiology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / virology
  • SARS-CoV-2

Substances

  • remdesivir
  • Adenosine Monophosphate
  • Alanine